Atlanta Gastroenterology Specialists PC

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Crohn's disease3 trials
• Ulcerative colitis3 trials

Phase

• Phase 33 trials
• Phase 2/31 trial

Status

• Completed3 trials
• Active, not recruiting1 trial

Lead sponsor

• Eli Lilly and Company1 trial
• Janssen Research & Development, LLC1 trial
• Shire1 trial
• Takeda1 trial

Running trials

• Active, not recruiting

  A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT03466411· Phase 2/3· Janssen Research & Development, LLC· Source

Closed trials

• Completed

  An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

  NCT03518086· Phase 3· Eli Lilly and Company· Source

• Completed

  A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)

  NCT03283085· Phase 3· Shire· Source

• Completed

  A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease

  NCT02620046· Phase 3· Takeda· Source